File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1111/j.1600-051X.2005.00785.x
- Scopus: eid_2-s2.0-25844460542
- PMID: 16128833
- WOS: WOS:000232374300010
- Find via
Supplementary
-
Bookmarks:
- CiteULike: 1
- Citations:
- Appears in Collections:
Conference Paper: Host response modulation in the management of periodontal diseases
Title | Host response modulation in the management of periodontal diseases |
---|---|
Authors | |
Keywords | Cytokines Gingivitis Host modulation Inflammation Periodontitis Prostaglandins |
Issue Date | 2005 |
Publisher | Blackwell Munksgaard. The Journal's web site is located at http://www.blackwellpublishing.com/journals/CPE |
Citation | Journal Of Clinical Periodontology, 2005, v. 32 SUPPL. 6, p. 108-129 How to Cite? |
Abstract | Objective: To review the biological mechanisms and clinical utility of therapeutic modulation of the host response in the management of periodontal diseases. Material and methods: A search of MEDLINE-PubMed was performed up to and including December 2004. The search was limited to in vitro, experimental animal and clinical studies published in English. The selection criteria included all levels of available evidence: systematic reviews, randomised-controlled clinical trials, controlled clinical trials, prospective and retrospective cohort studies and case reports of human and experimental animal studies. Results: Six targets for non-microbial chemotherapeutic intervention were identified. Clinical trials have demonstrated the ability of non-steroidal anti-inflammatory drugs to slow periodontal disease progression. However, recently reported serious adverse effects preclude the use of cyclooxygenase-2 inhibitors as an adjunct to periodontal therapy. Adjunctive use of subantimicrobial dose doxycycline to non-surgical periodontal therapy is beneficial in the management of chronic periodontitis over 12 months. Controversial data exist on the effects of bisphosphonate administration as an adjunct to periodontal therapy. Evidence on modulation of other host mediators including lipoxins, cytokines and nitric oxide synthase is limited to animal research. Conclusion: After validation in long-term clinical trials, adjunctive host modulation therapy may prove advantageous in the management of periodontal diseases. © Blackwell Munksgaard 2005. |
Persistent Identifier | http://hdl.handle.net/10722/157951 |
ISSN | 2023 Impact Factor: 5.8 2023 SCImago Journal Rankings: 2.249 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Salvi, GE | en_US |
dc.contributor.author | Lang, NP | en_US |
dc.date.accessioned | 2012-08-08T08:57:08Z | - |
dc.date.available | 2012-08-08T08:57:08Z | - |
dc.date.issued | 2005 | en_US |
dc.identifier.citation | Journal Of Clinical Periodontology, 2005, v. 32 SUPPL. 6, p. 108-129 | en_US |
dc.identifier.issn | 0303-6979 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/157951 | - |
dc.description.abstract | Objective: To review the biological mechanisms and clinical utility of therapeutic modulation of the host response in the management of periodontal diseases. Material and methods: A search of MEDLINE-PubMed was performed up to and including December 2004. The search was limited to in vitro, experimental animal and clinical studies published in English. The selection criteria included all levels of available evidence: systematic reviews, randomised-controlled clinical trials, controlled clinical trials, prospective and retrospective cohort studies and case reports of human and experimental animal studies. Results: Six targets for non-microbial chemotherapeutic intervention were identified. Clinical trials have demonstrated the ability of non-steroidal anti-inflammatory drugs to slow periodontal disease progression. However, recently reported serious adverse effects preclude the use of cyclooxygenase-2 inhibitors as an adjunct to periodontal therapy. Adjunctive use of subantimicrobial dose doxycycline to non-surgical periodontal therapy is beneficial in the management of chronic periodontitis over 12 months. Controversial data exist on the effects of bisphosphonate administration as an adjunct to periodontal therapy. Evidence on modulation of other host mediators including lipoxins, cytokines and nitric oxide synthase is limited to animal research. Conclusion: After validation in long-term clinical trials, adjunctive host modulation therapy may prove advantageous in the management of periodontal diseases. © Blackwell Munksgaard 2005. | en_US |
dc.language | eng | en_US |
dc.publisher | Blackwell Munksgaard. The Journal's web site is located at http://www.blackwellpublishing.com/journals/CPE | en_US |
dc.relation.ispartof | Journal of Clinical Periodontology | en_US |
dc.subject | Cytokines | - |
dc.subject | Gingivitis | - |
dc.subject | Host modulation | - |
dc.subject | Inflammation | - |
dc.subject | Periodontitis | - |
dc.subject | Prostaglandins | - |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Anti-Inflammatory Agents, Non-Steroidal - Therapeutic Use | en_US |
dc.subject.mesh | Arachidonic Acid - Antagonists & Inhibitors | en_US |
dc.subject.mesh | Bone Remodeling - Drug Effects | en_US |
dc.subject.mesh | Cyclooxygenase Inhibitors - Therapeutic Use | en_US |
dc.subject.mesh | Dental Scaling | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Inflammation Mediators - Therapeutic Use | en_US |
dc.subject.mesh | Lipoxins - Physiology | en_US |
dc.subject.mesh | Matrix Metalloproteinases - Antagonists & Inhibitors - Metabolism | en_US |
dc.subject.mesh | Nitric Oxide Synthase - Antagonists & Inhibitors - Metabolism | en_US |
dc.subject.mesh | Periodontitis - Drug Therapy - Metabolism | en_US |
dc.subject.mesh | Protease Inhibitors - Pharmacology - Therapeutic Use | en_US |
dc.subject.mesh | Receptors, Cytokine - Drug Effects | en_US |
dc.title | Host response modulation in the management of periodontal diseases | en_US |
dc.type | Conference_Paper | en_US |
dc.identifier.email | Lang, NP:nplang@hkucc.hku.hk | en_US |
dc.identifier.authority | Lang, NP=rp00031 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1111/j.1600-051X.2005.00785.x | en_US |
dc.identifier.pmid | 16128833 | - |
dc.identifier.scopus | eid_2-s2.0-25844460542 | en_US |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-25844460542&selection=ref&src=s&origin=recordpage | en_US |
dc.identifier.volume | 32 | en_US |
dc.identifier.issue | SUPPL. 6 | en_US |
dc.identifier.spage | 108 | en_US |
dc.identifier.epage | 129 | en_US |
dc.identifier.isi | WOS:000232374300010 | - |
dc.publisher.place | Denmark | en_US |
dc.identifier.scopusauthorid | Salvi, GE=35600695300 | en_US |
dc.identifier.scopusauthorid | Lang, NP=7201577367 | en_US |
dc.identifier.citeulike | 912862 | - |
dc.identifier.issnl | 0303-6979 | - |